In summary, we found that PFKFB3 is highly expressed in stromal cells in IBD and that inhibition of PFKFB3 reduces inflammatory cytokine secretion by fibroblasts in vitro and attenuates in vivo experimental models of colitis. This evidence concerns the gene PFKFB3 and colitis.